Editas Medicine to Host Strategic Update Webinar to Detail Progress Towards 2024 Goals, Including Achievement of Establishing In Vivo Preclinical Proof of Concept - Editas Medicine ( NASDAQ:EDIT )

6 hours ago

CAMBRIDGE, Mass., Oct. 18, 2024 ( GLOBE NEWSWIRE ) -- Editas Medicine, Inc. EDIT, a clinical-stage gene editing company, today announced that it will host a Company-sponsored webinar on Tuesday, October 22, 2024, at 8:00 a.m.

Ticker	Sentiment	Impact
EDIT	Somewhat Bullish	84 %